Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Immunity Année : 2016

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

1 UMR 1015 - Immunologie des tumeurs et immunothérapie
2 CIIL - Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204
3 U2RM - Unité de Recherche Risques Microbiens
4 CIC 1428 , CBT 507 - Centre d'Investigation Clinique en Biotherapie des cancers
5 MICALIS - MICrobiologie de l'ALImentation au Service de la Santé
6 Département d'oncologie médicale [Centre Georges-François Leclerc]
7 LNC - Lipides - Nutrition - Cancer (U866)
8 CHU Saint-Antoine [AP-HP]
9 UPMC - Université Pierre et Marie Curie - Paris 6
10 Plateforme de métabolomique
11 U848 - Apoptose, cancer et immunité
12 CRC - Centre de Recherche des Cordeliers
13 Service de biologie [CHU HEGP]
14 IGR - Institut Gustave Roussy
15 UPD5 - Université Paris Descartes - Paris 5
16 PARCC - UMR-S U970 - Paris-Centre de Recherche Cardiovasculaire
17 CBMCT - UMR 3666 / U1143 - Chimie biologique des membranes et ciblage thérapeutique
18 Microbiologie
19 Université Paris-Saclay
20 Department Radiation Oncology (Weill Cornell Medicine)
21 Monash University [Clayton]
22 ULD - Unabhängiges Landeszentrum für Datenschutz Schleswig-Holstein [Kiel, Germany]
23 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
24 URMITE - Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes
25 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
26 BGPB - Biologie et Génétique de la Paroi bactérienne - Biology and Genetics of Bacterial Cell Wall
Eric Tartour
Elisabeth Chachaty
  • Fonction : Auteur

Résumé

The efficacy of the anti-cancer immunomodulatory agent cyclophosphamide (CTX) relies on intestinal bacteria. How and which relevant bacterial species are involved in tumor immunosurveillance, and their mechanism of action are unclear. Here, we identified two bacterial species, Enterococcus hirae and Barnesiella intestinihominis that are involved during CTX therapy. Whereas E. hirae translocated from the small intestine to secondary lymphoid organs and increased the intratumoral CD8/ Treg ratio, B. intestinihominis accumulated in the colon and promoted the infiltration of IFN-gamma-producing gamma delta Tau cells in cancer lesions. The immune sensor, NOD2, limited CTX-induced cancer immunosurveillance and the bioactivity of these microbes. Finally, E. hirae and B. intestinihominis specific-memory Th1 cell immune responses selectively predicted longer progression-free survival in advanced lung and ovarian cancer patients treated with chemo-immunotherapy. Altogether, E. hirae and B. intestinihominis represent valuable ''oncomicrobiotics'' ameliorating the efficacy of the most common alkylating immunomodulatory compound.

Dates et versions

hal-01429856 , version 1 (09-01-2017)

Identifiants

Citer

Romain Daillère, Marie Vétizou, Nadine Waldschmitt, Takahiro Yamazaki, Christophe Isnard, et al.. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity, 2016, 45 (4), pp.931 - 943. ⟨10.1016/j.immuni.2016.09.009⟩. ⟨hal-01429856⟩
748 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More